Literature DB >> 26827652

Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.

Timothy J Hohman1, William S Bush2, Lan Jiang3, Kristin D Brown-Gentry3, Eric S Torstenson3, Scott M Dudek3, Shubhabrata Mukherjee4, Adam Naj5, Brian W Kunkle6, Marylyn D Ritchie7, Eden R Martin8, Gerard D Schellenberg9, Richard Mayeux10, Lindsay A Farrer11, Margaret A Pericak-Vance12, Jonathan L Haines2, Tricia A Thornton-Wells13.   

Abstract

Late-onset Alzheimer disease (AD) has a complex genetic etiology, involving locus heterogeneity, polygenic inheritance, and gene-gene interactions; however, the investigation of interactions in recent genome-wide association studies has been limited. We used a biological knowledge-driven approach to evaluate gene-gene interactions for consistency across 13 data sets from the Alzheimer Disease Genetics Consortium. Fifteen single nucleotide polymorphism (SNP)-SNP pairs within 3 gene-gene combinations were identified: SIRT1 × ABCB1, PSAP × PEBP4, and GRIN2B × ADRA1A. In addition, we extend a previously identified interaction from an endophenotype analysis between RYR3 × CACNA1C. Finally, post hoc gene expression analyses of the implicated SNPs further implicate SIRT1 and ABCB1, and implicate CDH23 which was most recently identified as an AD risk locus in an epigenetic analysis of AD. The observed interactions in this article highlight ways in which genotypic variation related to disease may depend on the genetic context in which it occurs. Further, our results highlight the utility of evaluating genetic interactions to explain additional variance in AD risk and identify novel molecular mechanisms of AD pathogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Biofilter; Epistasis; Gene-gene interactions

Mesh:

Substances:

Year:  2015        PMID: 26827652      PMCID: PMC4735733          DOI: 10.1016/j.neurobiolaging.2015.10.031

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  66 in total

1.  Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project.

Authors:  Heike Kölsch; Donald J Lehmann; Carla A Ibrahim-Verbaas; Onofre Combarros; Cornelia M van Duijn; Naomi Hammond; Olivia Belbin; Mario Cortina-Borja; Michael G Lehmann; Yurii S Aulchenko; Maaike Schuur; Monique Breteler; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Ignacio Mateo; Wolfgang Maier; Kevin Morgan; Donald R Warden; A David Smith; Reinhard Heun
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

2.  Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk.

Authors:  I Mateo; J Infante; E Rodríguez; J Berciano; O Combarros; J Llorca
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

3.  INTERSNP: genome-wide interaction analysis guided by a priori information.

Authors:  Christine Herold; Michael Steffens; Felix F Brockschmidt; Max P Baur; Tim Becker
Journal:  Bioinformatics       Date:  2009-10-16       Impact factor: 6.937

4.  Genetic variants of CDH23 associated with noise-induced hearing loss.

Authors:  Tomasz Jarema Kowalski; Malgorzata Pawelczyk; Elzbieta Rajkowska; Adam Dudarewicz; Mariola Sliwinska-Kowalska
Journal:  Otol Neurotol       Date:  2014-02       Impact factor: 2.311

5.  Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1.

Authors:  Freya G G Vercauteren; Stefan Clerens; Line Roy; Nathalie Hamel; Lut Arckens; Frans Vandesande; Leena Alhonen; Juhani Janne; Moshe Szyf; A Claudio Cuello
Journal:  Brain Res Mol Brain Res       Date:  2004-12-20

6.  MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.

Authors:  Diana Kuhnke; Gabriele Jedlitschky; Markus Grube; Markus Krohn; Mathias Jucker; Igor Mosyagin; Ingolf Cascorbi; Lary C Walker; Heyo K Kroemer; Rolf W Warzok; Silke Vogelgesang
Journal:  Brain Pathol       Date:  2007-07-04       Impact factor: 6.508

7.  Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.

Authors:  Beatrice Arosio; Daria Trabattoni; Lorenza Galimberti; Paolo Bucciarelli; Francesca Fasano; Carmen Calabresi; Carlo Lorenzo Cazzullo; Carlo Vergani; Giorgio Annoni; Mario Clerici
Journal:  Neurobiol Aging       Date:  2004-09       Impact factor: 4.673

8.  The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Authors:  Onofre Combarros; Donald R Warden; Naomi Hammond; Mario Cortina-Borja; Olivia Belbin; Michael G Lehmann; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Rhian Gwilliam; Reinhard Heun; Heike Kölsch; Ignacio Mateo; Abderrahim Oulhaj; Alejandro Arias-Vásquez; Maaike Schuur; Yurii S Aulchenko; M Arfan Ikram; Monique M Breteler; Cornelia M van Duijn; Kevin Morgan; A David Smith; Donald J Lehmann
Journal:  BMC Med Genet       Date:  2010-11-11       Impact factor: 2.103

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

Authors:  S L Spinelli; J J O'Brien; S Bancos; G M Lehmann; D L Springer; N Blumberg; C W Francis; M B Taubman; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more
  16 in total

1.  Association of CD14-260 (-159) C/T and Alzheimer's disease: systematic review and trial sequential analyses.

Authors:  Yan Wang; Xiaoling Wu; Xun Deng; Yanjiao Ma; Siyi Huang; Yong Wang
Journal:  J Neural Transm (Vienna)       Date:  2018-06-20       Impact factor: 3.575

Review 2.  Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.

Authors:  Nada A Elsayed; Kaila M Yamamoto; Tanya E Froehlich
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

Review 3.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

4.  Genetic epistasis regulates amyloid deposition in resilient aging.

Authors:  Daniel Felsky; Jishu Xu; Lori B Chibnik; Julie A Schneider; Jo Knight; James L Kennedy; David A Bennett; Philip L De Jager; Aristotle N Voineskos
Journal:  Alzheimers Dement       Date:  2017-03-17       Impact factor: 21.566

5.  Genetic risk for coronary heart disease alters the influence of Alzheimer's genetic risk on mild cognitive impairment.

Authors:  Jeremy A Elman; Matthew S Panizzon; Mark W Logue; Nathan A Gillespie; Michael C Neale; Chandra A Reynolds; Daniel E Gustavson; Brinda K Rana; Ole A Andreassen; Anders M Dale; Carol E Franz; Michael J Lyons; William S Kremen
Journal:  Neurobiol Aging       Date:  2019-06-08       Impact factor: 4.673

Review 6.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

7.  Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders.

Authors:  Ileena Mitra; Alinoë Lavillaureix; Erika Yeh; Michela Traglia; Kathryn Tsang; Carrie E Bearden; Katherine A Rauen; Lauren A Weiss
Journal:  PLoS Genet       Date:  2017-01-11       Impact factor: 5.917

8.  The association of MPO gene promoter polymorphisms with Alzheimer's disease risk in Chinese Han population.

Authors:  Wenzhen Ji; Yu Zhang
Journal:  Oncotarget       Date:  2017-11-06

9.  A statistical framework for cross-tissue transcriptome-wide association analysis.

Authors:  Yiming Hu; Mo Li; Qiongshi Lu; Haoyi Weng; Jiawei Wang; Seyedeh M Zekavat; Zhaolong Yu; Boyang Li; Jianlei Gu; Sydney Muchnik; Yu Shi; Brian W Kunkle; Shubhabrata Mukherjee; Pradeep Natarajan; Adam Naj; Amanda Kuzma; Yi Zhao; Paul K Crane; Hui Lu; Hongyu Zhao
Journal:  Nat Genet       Date:  2019-02-25       Impact factor: 38.330

10.  Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

Authors:  Mireia Pagerols; Vanesa Richarte; Cristina Sánchez-Mora; Paula Rovira; María Soler Artigas; Iris Garcia-Martínez; Eva Calvo-Sánchez; Montse Corrales; Bruna Santos da Silva; Nina Roth Mota; Marcelo Moraes Victor; Luis Augusto Rohde; Eugenio Horacio Grevet; Claiton Henrique Dotto Bau; Bru Cormand; Miguel Casas; Josep Antoni Ramos-Quiroga; Marta Ribasés
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.